Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial-Reference-Cited by-同舟云学术

Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial

Published:2017-07-13 Issue:10 Volume:19 Page:1397-1407
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Terauchi Yasuo¹,Tamura Masahiro²,Senda Masayuki³,Gunji Ryoji⁴,Kaku Kohei⁵

Affiliation:

1. Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine; Yokohama Japan

2. Diabetes and Cardiovascular Medical Operations; Sanofi K.K.; Tokyo Japan

3. Medical Affairs; Sanofi K.K.; Tokyo Japan

4. Post Marketing Surveillance Department; Kowa Company, Ltd.; Tokyo Japan

5. Department of General Internal Medicine; Kawasaki Medical School; Kurashiki Japan

Funder

Sanofi K.K. and Kowa Company, Ltd.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12957/fullpdf

Reference41 articles.

1. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment;Halban;Diabetes Care,2014

2. Identifying and meeting the challenges of insulin therapy in type 2 diabetes;Sorli;J Multidiscip Healthc,2014

3. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?;Massi-Benedetti;Diabetes Care,2008

4. Approaches to glycemic treatment;American Diabetes Association;Diabetes Care,2016

5. Clinical inquiries. What is the role of combination therapy (insulin plus oral medication) in type 2 diabetes?;Eskesen;J Fam Pract,2006

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice;Journal of Diabetes Investigation;2024-08-14

2. Effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on serum uric acid levels in patients with chronic kidney disease: a systematic review and network meta-analysis;BMJ Open Diabetes Research & Care;2024-01

3. The impact of sodium-glucose Cotransporter-2 inhibitors on lipid profile: A meta-analysis of 28 randomized controlled trials;European Journal of Pharmacology;2023-11

4. Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2023-08-28

5. Renal, cardiovascular, and safety outcomes of adding sodium–glucose cotransporter-2 inhibitors to insulin therapy in patients with type-2 diabetes: a meta-analysis;International Urology and Nephrology;2023-07-29